Healthy Living

This Might Be The Future of Hodgkin Lymphoma Treatment

At first, Adcetris was a last resort

Adcetris has actually been around since 2011. It was only used them for people who had Hodgkin's for the second time after already getting a stem cell transplant or at least two other chemotherapy cocktails. It was really a last resort type of medication back then. But the miracles doctors witnessed in relapse patients using this drug drew attention. When there was a bleomycin shortage in 2016, doctors at Stanford started to use Adcetris for their advanced stage patients.